Novel Immune-Based Therapies for Life-Limiting Diseases NovaBiotics develops immune based therapies for life-threatening and life-limiting diseases. The novel therapies NovaBiotics is developing serve immunocompromised patients who are susceptible to fungal and bacterial infections and also patients with complex, inflammatory-infectious disease of the airways and other tissues and organs. NovaBiotics has generated two proprietary immunotherapy platforms (a peptide and small molecule platform) and the high value...
Supporting the Identification of Lead Compounds in Early Drug Discovery Our customers tend to come to us at an early stage of the drug discovery project. They may come to us with a specific target in mind, or a problem that requires specialist expertise that they do not have in house. For our integrated drug discovery customers, their projects may involve utilising our medicinal chemistry...
Addressing the Global Challenge of Alzheimer’s Disease TauRx’s mission is to discover, develop and commercialise innovative products for the diagnosis, treatment, and cure of neurodegenerative diseases such as Alzheimer’s disease (AD) caused through protein aggregation. Dementia is the world’s greatest unmet medical need. As the world’s population ages, the prevalence of AD, the most common form of dementia, is predicted to reach epidemic proportions. Our...